Phytochem Remedies’ IPO withdrawal: Check the reasons.

Phytochem Remedies (India) Limited has withdrawn its IPO of ₹38 crore. The reason could be the undersubscription of this IPO on the last day due to market uncertainty. According to the sources, this IPO has received only 797 applications during the subscription period.

An in-depth look at the reasons behind the Phytochem Remedies IPO cancellation is provided below.

Why was the Phytochem Remedies IPO cancelled?

As per the sources, the management decided to cancel the IPO of ₹38 crores because of capital market volatility, which forces investors to change their sentiments.

Accordingly, the Company shall not be proceeding with the Issue and requests you to kindly take note of the same,” Sharma said in a filing.

On Monday, the Phytochem Remedies IPO subscription was completed, resulting in approx 797 bids. The IPO has received around 23.1 lakh shares, raising about ₹22.63 crore.

Withdrawal Latter of Public issue – Click Here

Phytochem Remedies IPO details

The Phytochem Remedies IPO was open from December 18 to 22, 2025. It was a fresh issue worth ₹38.22 crore, with 1,200 shares in each lot. The price band is set at ₹98 per share. The IPO was expected to be listed on the BSE and NSE on December 26, 2025.

During the subscription, this IPO was subscribed to only 0.57 times by day three. Wherein, the retailer’s contributions were 0.83 times, non-institutional investors showed low interest at 0.31 times, while market makers fully participated at 1.00 times.

Vijay Prajapati

An experienced stock market professional with expertise in IPO research, market insights, and equity strategies. With a strong background in research and capital markets, he delivers comprehensive coverage on upcoming IPOs, subscription patterns, grey market premium (GMP), and post-listing performance, along with detailed reviews, recommendations, and technical analysis.

Add IPOWatch to your Google News feed.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.